Get the latest Science News and Discoveries

Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer - EurekAlert


<p>Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy &ndash; given before and after surgery &ndash; significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell&nbsp;lung cancer(NSCLC), according to&nbsp;researchers from The University of Texas MD Anderson Cancer Center.</p>

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of patients

patients

Photo of operable lung cancer

operable lung cancer

Photo of outcomes

outcomes

Related news:

News photo

Acta Pharmaceutica Sinica B Volume 14, Issue 5 Publishes - EurekAlert

News photo

Bar-Ilan University researchers develop innovative platform for modeling human muscle diseases in worms - EurekAlert

News photo

Singing researchers find cross-cultural patterns in music and language - EurekAlert